Free Webinar - PRIME scheme – A tailored development

In 2016, the European Medicines Agency (EMA) launched the PRIority MEdicines (PRIME) scheme to expedite the development and regulatory approval of medicines addressing major public health needs. The PRIME scheme aims to ensure robust data generation for regulatory compliance and to identify emerging issues early in development. It focuses on medicinal products targeting unmet medical needs to help them reach patients sooner and potentially enhance their quality of life.

Join our expert Alessia Cipriani to gain valuable insights on PRIME Scheme. Learn how Zwiers Regulatory Consultancy BV, part of ProductLife Group can support you. 

EVENT FINISHED.